Dova Pharmaceuticals (NASDAQ:DOVA) Insider Buying and Selling Activity
Insider Ownership Percentage: 55.50%
Dova Pharmaceuticals (NASDAQ DOVA) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/7/2019 | Paul B Manning | Director | Buy | 68,000 | $7.48 | $508,640.00 | |  |
| 12/20/2018 | David Zaccardelli | CEO | Buy | 10,000 | $6.07 | $60,700.00 | | |
| 12/20/2018 | Paul B Manning | Director | Buy | 266,631 | $6.17 | $1,645,113.27 | | |
| 8/14/2018 | Alex Sapir | CEO | Buy | 21,700 | $22.83 | $495,411.00 | | |
| 6/21/2018 | Steven M Goldman | Director | Buy | 5,000 | $30.22 | $151,100.00 | | |
| 6/11/2018 | Life Sciences Maste Perceptive | Major Shareholder | Buy | 19,700 | $29.36 | $578,392.00 | | |
| 6/8/2018 | Life Sciences Maste Perceptive | Major Shareholder | Buy | 25,000 | $28.65 | $716,250.00 | | |
| 6/7/2018 | Paul B Manning | Director | Buy | 27,000 | $28.42 | $767,340.00 | | |
| 6/6/2018 | Life Sciences Maste Perceptive | Major Shareholder | Buy | 100,000 | $28.66 | $2,866,000.00 | | |
| 6/5/2018 | Paul B Manning | Director | Buy | 120,000 | $26.17 | $3,140,400.00 | | |
| 6/4/2018 | Life Sciences Maste Perceptive | Major Shareholder | Buy | 10,000 | $25.07 | $250,700.00 | | |
| 8/16/2017 | Paul B Manning | Director | Buy | 25,870 | $22.30 | $576,901.00 | | |
| 8/15/2017 | Steven M Goldman | Director | Buy | 20,169 | $22.23 | $448,356.87 | 81,158 | |
| 7/5/2017 | Alex Sapir | CEO | Buy | 20,100 | $17.00 | $341,700.00 | 20,100 | |
| 7/5/2017 | Kevin Laliberte | VP | Buy | 6,200 | $17.00 | $105,400.00 | 6,200 | |
| 7/5/2017 | Lee F Md Phd Allen | Insider | Buy | 3,500 | $17.00 | $59,500.00 | 3,500 | |
| 7/5/2017 | Steven M Goldman | Director | Buy | 72,000 | $17.94 | $1,291,680.00 | 42,000 | |
(Data available from 1/1/2013 forward)
